1. Erratum to: EMA list of important medical events

   News item 17 September 2016 Pages: 1 - 1

2. Medsafe reports cases of drug-induced gynaecomastia

   News item 17 September 2016 Pages: 2 - 2

3. New drug safety labelling changes database established

   News item 17 September 2016 Pages: 3 - 3

4. PMDA issues reminder of lung disease with EGFR-TKIs

   News item 17 September 2016 Pages: 4 - 4

5. US FDA issues final rule on OTC antibacterial washes

   News item 17 September 2016 Pages: 5 - 5

6. New education programme to improve medication safety in US

   News item 17 September 2016 Pages: 6 - 6

7. Antipsychotics associated with higher risk of pneumonia

   Clinical study 17 September 2016 Pages: 7 - 7

8. Childhood antibiotics increase subsequent allergy risk

   Media release 17 September 2016 Pages: 8 - 8

9. Pandemic influenza vaccine associated with narcolepsy?

   Clinical study 17 September 2016 Pages: 9 - 9

10. Safety of adding long-acting β-agonist therapy

    Clinical study 17 September 2016 Pages: 10 - 10

11. Statins: efficacy and safety evidence reviewed

    Review 17 September 2016 Pages: 11 - 11

12. UK paediatric spontaneous ADR reporting rate low

    Clinical study 17 September 2016 Pages: 12 - 12

13. Abacavir

    Case report 17 September 2016 Pages: 13 - 13

14. Acitretin

    Case report 17 September 2016 Pages: 14 - 14

15. Adalimumab

    Case report 17 September 2016 Pages: 15 - 15

16. Adalimumab/etanercept

    Case report 17 September 2016 Pages: 16 - 16

17. Afatinib

    Case report 17 September 2016 Pages: 17 - 17

18. Alemtuzumab

    Case report 17 September 2016 Pages: 18 - 18

19. Alendronic acid/methotrexate

    Case report 17 September 2016 Pages: 19 - 19

20. Aluminium/colchicum alkaloids/tetanus vaccine

    Case report 17 September 2016 Pages: 20 - 20

21. Ambenonium chloride

    Case report 17 September 2016 Pages: 21 - 21

22. Amiodarone/sofosbuvir interaction and simeprevir

    Case report 17 September 2016 Pages: 22 - 22

23. Amoxicillin

    Case report 17 September 2016 Pages: 23 - 23

24. Amphotericin B liposomal

    Case report 17 September 2016 Pages: 24 - 24

25. Anabolic steroids/oxandrolone/stanozolol/testosterone

    Case report 17 September 2016 Pages: 25 - 25

26. Anakinra/tocilizumab

    Case report 17 September 2016 Pages: 26 - 26

27. Antineoplastics

    Case report 17 September 2016 Pages: 27 - 27

28. Antineoplastics

    Case report 17 September 2016 Pages: 28 - 28

29. Antineoplastics/lamivudine

    Case report 17 September 2016 Pages: 29 - 29

30. Antiretrovirals

    Case report 17 September 2016 Pages: 30 - 30

31. Antithymocyte globulin

    Case report 17 September 2016 Pages: 31 - 31

32. Antituberculars

    Case report 17 September 2016 Pages: 32 - 32

33. Apixaban

    Case report 17 September 2016 Pages: 33 - 33

34. Apixaban

    Case report 17 September 2016 Pages: 34 - 34

35. Asparaginase/pegaspargase

    Case report 17 September 2016 Pages: 35 - 35

36. Asunaprevir/daclatasvir

    Case report 17 September 2016 Pages: 36 - 36

37. Atomoxetine/risperidone

    Case report 17 September 2016 Pages: 37 - 37

38. Azacitidine

    Case report 17 September 2016 Pages: 38 - 38

39. Azathioprine

    Case report 17 September 2016 Pages: 39 - 39

40. Azithromycin/pregabalin interaction

    Case report 17 September 2016 Pages: 40 - 40

41. Baclofen

    Case report 17 September 2016 Pages: 41 - 41

42. Baclofen overdose

    Case report 17 September 2016 Pages: 42 - 42

43. Barium

    Case report 17 September 2016 Pages: 43 - 43

44. BCG vaccine

    Case report 17 September 2016 Pages: 44 - 44

45. BCG vaccine

    Case report 17 September 2016 Pages: 45 - 45

46. Benzathine-benzylpenicillin

    Case report 17 September 2016 Pages: 46 - 46

47. Betamethasone/prednisolone

    Case report 17 September 2016 Pages: 47 - 47

48. Bevacizumab/paclitaxel

    Case report 17 September 2016 Pages: 48 - 48

49. Bortezomib/dexamethasone/doxorubicin liposomal

    Case report 17 September 2016 Pages: 49 - 49

50. Bupivacaine/pethidine

    Case report 17 September 2016 Pages: 50 - 50